Fuller departure
This article was originally published in The Tan Sheet
Executive Summary
NACDS President & CEO Craig Fuller is resigning as of April 7, the exec confirms in his weekly newsletter March 20. "When it comes time to explore new directions and new leadership, presidents and boards are supposed to send a signal that it is time for a change. That signal has been sent in a remarkably professional and constructive manner," Fuller says. The chain drug store association indicated March 14 that its board had met with Fuller, who had offered his resignation (1"The Tan Sheet" March 20, 2006 , In Brief)...
You may also be interested in...
NACDS president Hannan
Robert Hannan has been named interim president & CEO of the National Association of Chain Drug Stores, effective April 3, the organization announces March 31. Hannan, a veteran in the chain drug industry with over 40 years experience, has served as president of Thrift Drug and vice chairman of Eckerd Drug after its acquisition of the Thrift Drug chain, according to NACDS. Having since retired from the industry, he currently runs his own consulting firm, Hannan Executive Services, Inc. The exec previously served as interim NACDS president in 1999. Hannan replaces Craig Fuller, who resigned as president & CEO March 20 (1"The Tan Sheet" March 27, 2006, In Brief). Exec VP & COO Bill Sittmann, who served in the White House with Fuller under Bush and Reagan, also resigned from NACDS March 31...
Fuller departing NACDS?
The Board of the National Association of Chain Drug Stores is discussing the possible departure of CEO Craig Fuller, the association states March 14. Fuller has met with the Board and Chairman Anthony Civello (Kerr Drug) to discuss the matter and has offered to tender his resignation, but no decision has been made, NACDS says. However, the board did indicate it was moving in a different direction, the association said. The drug store space finds itself under pressure from reduced pharmacy reimbursement under the Medicaid program and the potential of an FDA-mandated electronic pedigree system for tracking drugs. The upper limit for reimbursement of multiple source drugs under Medicaid was modified in the Deficit Reduction Act (S 1932), which was largely considered a setback for pharmacy. Fuller had been cautiously optimistic that the bill's passage could be blocked, but it narrowly passed Congress with Vice President Cheney casting a tie-breaking vote. Fuller has worked in the White House under Presidents Reagan and Bush...
Prestige Expands UK Eye Care Range In Response To Consumer Demand
A “great consumer response” to TheraTears in the UK leads Prestige Consumer Healthcare to add TheraTears 5-in-1 Irritation and Redness eye drops to the range.